These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 22796372)
1. Clinical significance of serum and tissue Dickkopf-1 levels in patients with gastric cancer. Lee HS; Lee HE; Park DJ; Kim HH; Kim WH; Park KU Clin Chim Acta; 2012 Nov; 413(21-22):1753-60. PubMed ID: 22796372 [TBL] [Abstract][Full Text] [Related]
2. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer. Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance and prognostic value of serum Dickkopf-1 concentrations in patients with lung cancer. Sheng SL; Huang G; Yu B; Qin WX Clin Chem; 2009 Sep; 55(9):1656-64. PubMed ID: 19628661 [TBL] [Abstract][Full Text] [Related]
4. Serum Dickkopf-1 acts as a new biomarker in human breast cancer. Liu JT; Guo WB; Sun JY Minerva Med; 2017 Aug; 108(4):334-340. PubMed ID: 28248066 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of Dickkopf-1 and ß-catenin expression in advanced gastric cancer. Hong SA; Yoo SH; Lee HH; Sun S; Won HS; Kim O; Ko YH BMC Cancer; 2018 May; 18(1):506. PubMed ID: 29720122 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer. Kim JH; Jun KH; Jung H; Park IS; Chin HM Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088 [TBL] [Abstract][Full Text] [Related]
7. Assessing the diagnostic value of serum Dickkopf-related protein 1 levels in cancer detection: a case-control study and meta-analysis. Jiang XT; Ma YY; Guo K; Xia YJ; Wang HJ; Li L; He XJ; Huang DS; Tao HQ Asian Pac J Cancer Prev; 2014; 15(21):9077-83. PubMed ID: 25422182 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and prognostic significance of serum and tissue Dickkopf-1 levels in human hepatocellular carcinoma. Tung EK; Mak CK; Fatima S; Lo RC; Zhao H; Zhang C; Dai H; Poon RT; Yuen MF; Lai CL; Li JJ; Luk JM; Ng IO Liver Int; 2011 Nov; 31(10):1494-504. PubMed ID: 21955977 [TBL] [Abstract][Full Text] [Related]
9. A novel screening biomarker in gastric cancer: serum Dickkopf-1. Gomceli I; Bostanci EB; Ozer I; Kemik AS; Turhan N; Tez M; Kilic S; Demiriz B; Akoglu M Hepatogastroenterology; 2012; 59(117):1661-4. PubMed ID: 22155860 [TBL] [Abstract][Full Text] [Related]
10. Neuroblastoma and bone metastases: clinical significance and prognostic value of Dickkopf 1 plasma levels. Granchi D; Corrias MV; Garaventa A; Baglìo SR; Cangemi G; Carlini B; Paolucci P; Giunti A; Baldini N Bone; 2011 Jan; 48(1):152-9. PubMed ID: 20603237 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of REG4 for early diagnosis and prognosis of gastric cancer. Tao HQ; He XJ; Ma YY; Wang HJ; Xia YJ; Ye ZY; Zhao ZS Hum Pathol; 2011 Oct; 42(10):1401-9. PubMed ID: 21419474 [TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of Dickkopf-1 in Gastric Cancer Survival: A Meta-Analysis. Liu QR; Li YF; Deng ZQ; Cao JQ Genet Test Mol Biomarkers; 2016 Apr; 20(4):170-5. PubMed ID: 27023747 [TBL] [Abstract][Full Text] [Related]
13. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799 [TBL] [Abstract][Full Text] [Related]
14. The use of tumor markers as predictors of prognosis in gastric cancer. Mihmanli M; Dilege E; Demir U; Coskun H; Eroglu T; Uysalol MD Hepatogastroenterology; 2004; 51(59):1544-7. PubMed ID: 15362797 [TBL] [Abstract][Full Text] [Related]
15. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients. Toiyama Y; Tanaka K; Kitajima T; Shimura T; Imaoka H; Mori K; Okigami M; Yasuda H; Okugawa Y; Saigusa S; Ohi M; Inoue Y; Mohri Y; Goel A; Kusunoki M Carcinogenesis; 2015 Dec; 36(12):1474-83. PubMed ID: 26420253 [TBL] [Abstract][Full Text] [Related]
16. Serum macrophage migration-inhibitory factor as a diagnostic and prognostic biomarker for gastric cancer. Xia HH; Yang Y; Chu KM; Gu Q; Zhang YY; He H; Wong WM; Leung SY; Yuen ST; Yuen MF; Chan AO; Wong BC Cancer; 2009 Dec; 115(23):5441-9. PubMed ID: 19685530 [TBL] [Abstract][Full Text] [Related]
17. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer. Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284 [TBL] [Abstract][Full Text] [Related]